{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T16:41:46Z","timestamp":1783528906028,"version":"3.55.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jfo.2024.104334","type":"journal-article","created":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T16:03:24Z","timestamp":1730131404000},"page":"104334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Toxoplasmose oculaire"],"prefix":"10.1016","volume":"47","author":[{"given":"A.","family":"Sauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Schaeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Serrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Kodjikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2024.104334_bib0180","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jfo.2024.104334_bib0185","series-title":"Toxoplasmose oculaire, Rapport 2017 (Ophtalmologie p\u00e9diatrique) de la Soci\u00e9t\u00e9 fran\u00e7aise d\u2019ophtalmologie","author":"Kodjikian","year":"2017"},{"key":"10.1016\/j.jfo.2024.104334_bib0190","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1017\/S0950268813002756","article-title":"Incidence, and prevalence of Toxoplasma gondii infection in women in France, 1980-2020: model-based estimation","volume":"142","author":"Nogareda","year":"2014","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.jfo.2024.104334_bib0195","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1080\/09273948.2022.2117705","article-title":"Ocular toxoplasmosis","volume":"31","author":"Goh","year":"2023","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2024.104334_bib0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3109\/09273948.2012.661115","article-title":"Epidemiology of ocular toxoplasmosis","volume":"20","author":"Petersen","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2024.104334_bib0205","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1016\/j.jfo.2020.01.001","article-title":"Toxoplasmosis and behavioural changes","volume":"43","author":"Desmettre","year":"2020","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0210","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.310.6986.1037","article-title":"Incidence of acute symptomatic toxoplasma retinochoroiditis in south London according to country of birth","volume":"310","author":"Gilbert","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/j.jfo.2024.104334_bib0215","first-page":"1","article-title":"Recent developments in the diagnosis and treatment of ocular toxoplasmosis","volume":"57","author":"Ozgonul","year":"2017","journal-title":"ORE"},{"key":"10.1016\/j.jfo.2024.104334_bib0220","doi-asserted-by":"crossref","first-page":"e0008905","DOI":"10.1371\/journal.pntd.0008905","article-title":"Pathophysiology of ocular toxoplasmosis: facts and open questions","volume":"14","author":"Greigert","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.jfo.2024.104334_bib0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/INF.0b013e3181658abb","article-title":"Toxoplasmosis in children","volume":"27","author":"McAuley","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jfo.2024.104334_bib0230","doi-asserted-by":"crossref","first-page":"19600","DOI":"10.2807\/ese.15.25.19600-en","article-title":"Toxosurv network and National Reference Centre for Toxoplasmosis. Congenital toxoplasmosis in France in 2007: first results from a national surveillance system","volume":"15","author":"Villena","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/j.jfo.2024.104334_bib0235","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00417-005-1164-3","article-title":"Ocular manifestations in congenital toxoplasmosis","volume":"244","author":"Kodjikian","year":"2006","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0240","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.parint.2018.07.004","article-title":"Congenital toxoplasmosis: an overview of the neurological and ocular manifestations","volume":"67","author":"Khan","year":"2018","journal-title":"Parasitol Int"},{"key":"10.1016\/j.jfo.2024.104334_bib0245","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1136\/bjo.84.2.224","article-title":"Is ocular toxoplasmosis caused by prenatal or postnatal infection?","volume":"84","author":"Gilbert","year":"2000","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0250","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.ajo.2008.06.027","article-title":"Respective roles of acquired and congenital infections in presumed ocular toxoplasmosis","volume":"146","author":"Delair","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0255","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ijfoodmicro.2012.03.029","article-title":"Disease burden of foodborne pathogens in the Netherlands, 2009","volume":"156","author":"Havelaar","year":"2012","journal-title":"Int J Food Microbiol"},{"key":"10.1016\/j.jfo.2024.104334_bib0260","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09273948.2011.564068","article-title":"Clinical manifestations of ocular toxoplasmosis","volume":"19","author":"Delair","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2024.104334_bib0265","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.preteyeres.2013.12.005","article-title":"Ocular toxoplasmosis past, present and new aspects of an old disease","volume":"39","author":"Maenz","year":"2014","journal-title":"Progr Retinal Eye Res"},{"key":"10.1016\/j.jfo.2024.104334_bib0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10792-021-01994-9","article-title":"Ocular toxoplasmosis: a review of the current diagnostic and therapeutic approaches","volume":"42","author":"Kalogeropoulos","year":"2022","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0275","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3928\/23258160-20190503-04","article-title":"Multimodal imaging of punctate outer retinal toxoplasmosis","volume":"50","author":"Yannuzzi","year":"2019","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.jfo.2024.104334_bib0280","doi-asserted-by":"crossref","first-page":"106180","DOI":"10.1016\/j.actatropica.2021.106180","article-title":"Ocular toxoplasmosis, an overview focusing on clinical aspects","volume":"225","author":"Fabiani","year":"2022","journal-title":"Acta Trop"},{"key":"10.1016\/j.jfo.2024.104334_bib0285","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00417-019-04313-2","article-title":"Monitoring of visual field over 6\u00a0months after active ocular toxoplasmosis","volume":"257","author":"Blot","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0290","doi-asserted-by":"crossref","first-page":"e00636","DOI":"10.1128\/mSphere.00636-19","article-title":"Biological diagnosis of ocular toxoplasmosis: a nine-year retrospective observational study","volume":"4","author":"Greigert","year":"2019","journal-title":"mSphere"},{"key":"10.1016\/j.jfo.2024.104334_bib0295","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/bjophthalmol-2019-313884","article-title":"When biology supports clinical diagnosis: review of techniques to diagnose ocular toxoplasmosis","volume":"103","author":"Greigert","year":"2019","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0300","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1136\/bjophthalmol-2017-311528","article-title":"Comparison of immunoblotting (IgA and IgG) and the Goldmann-Witmer coefficient for diagnosis of ocular toxoplasmosis in immunocompetent patients","volume":"102","author":"Mathis","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0305","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jfo.2021.11.007","article-title":"Management of ocular toxoplasmosis in France: results of a modified Delphi study","volume":"45","author":"Schaeffer","year":"2022","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0310","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3109\/09273948.2011.547157","article-title":"Controversies in ocular toxoplasmosis","volume":"19","author":"Wakefield","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.jfo.2024.104334_bib0315","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13643-019-1067-8","article-title":"Antibiotic treatment for ocular toxoplasmosis: a systematic review and meta-analysis: study protocol","volume":"8","author":"Feliciano-Alfonso","year":"2019","journal-title":"Syst Rev"},{"key":"10.1016\/j.jfo.2024.104334_bib0320","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.3390\/jcm10051090","article-title":"Treatment strategy in human ocular toxoplasmosis: why antibiotics have failed","volume":"10","author":"Garweg","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/j.jfo.2024.104334_bib0325","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1136\/bjophthalmol-2022-321091","article-title":"Current practice in the management of ocular toxoplasmosis","volume":"107","author":"Yogeswaran","year":"2023","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0330","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1097\/INF.0b013e3182129e70","article-title":"Prevention of retinochoroiditis in congenital toxoplasmosis: Europe versus South America","volume":"30","author":"Sauer","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jfo.2024.104334_bib0335","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.3390\/pathogens11101187","article-title":"Long-term outcomes in children with congenital toxoplasmosis-a systematic review","volume":"11","author":"Garweg","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.jfo.2024.104334_bib0340","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ajo.2019.12.025","article-title":"Long-term results of trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrent toxoplasma gondii retinochoroiditis","volume":"213","author":"Fernandes Felix","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0345","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ajo.2018.11.013","article-title":"Clinical and biological factors associated with recurrences of severe toxoplasmic retinochoroiditis confirmed by aqueous humor analysis","volume":"199","author":"Matet","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2024.104334_bib0175","first-page":"CD007417","article-title":"Corticosteroids as adjuvant therapy for ocular toxoplasmosis","volume":"1","author":"Jasper","year":"2017","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551224002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551224002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T14:24:34Z","timestamp":1733495074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551224002791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S0181551224002791"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2024.104334","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Toxoplasmose oculaire","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2024.104334","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104334"}}